Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

Drive-through phlebotomy

Laboratory Manager Richard Wardle outlines the introduction of a drive-through phlebotomy service during the COVID-19 pandemic.

Glucose-sensing neurons regulate blood sugar

Low blood sugar levels, known as hypoglycaemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

Setting up a Nightingale hospital transfusion service

Alison Muir, a Lead Scientist in Blood Transfusion, discusses the issues and challenges in setting up a transfusion service to help cope with the pandemic.

Top